Thompson Davis & Co’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
Thompson Davis & Co's ROSG Position: Q3 2014 in Review
Thompson Davis & Co sold out of Rosetta Genomics (ROSG) in Q3 2014, closing a stake of 83 shares.
Thompson Davis & Co first reported a position in ROSG in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 14 funds tracked by Wall St. Rank hold ROSG as of Q3 2014.
- Thompson Davis & Co reported no remaining Rosetta Genomics position as of Q3 2014 after selling out during the quarter.
- Thompson Davis & Co sold 83 Rosetta Genomics shares in Q3 2014.
- Thompson Davis & Co first reported a position in Rosetta Genomics in Q2 2014 and held it in 1 quarter.
- Thompson Davis & Co's Rosetta Genomics position peaked at $0 in Q2 2014.
- 14 funds tracked by Wall St. Rank held Rosetta Genomics as of Q3 2014.
Based on Thompson Davis & Co's 13F filing for Q3 2014, filed 4 Nov 2014.